CClinicalTrials.gg
TerminatedNCT04495738Updated May 14, 2021

Infant Formula and Toddler Drink Feeding Intervention

An interventional study of Control Infant Formula and Control Toddler Drink in Respiratory Infections in Children, sponsored by Abbott Nutrition. Terminated at 27 sites in United States. Open to participants aged Up to 14 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-14.

Sponsored by Abbott Nutrition · Not applicable, Interventional, and Other

Why this study was terminated
Change in research focus
Phase
Not applicable
Study type
Interventional
Enrollment
168
Allocation
Randomized
Ages
Up to 14 Days
Sex
All
01

Study summary

The purpose of this randomized, multi-center, controlled, double-blind, parallel study is to evaluate the health and developmental outcomes of children fed a new infant formula and toddler drink through 24 months of age.

02

Conditions studied

  • Respiratory Infections in Children
03

In context

Respiratory Tract Infections

1,031 studies on the registry are indexed under Respiratory Tract Infections; 144 are open to participants now.

This study's enrollment of 168 is below the median of 199 across 698 interventional studies indexed under Respiratory Tract Infections.

Browse Respiratory Tract Infections studies →

Lead sponsor

Abbott Nutrition is the lead sponsor of 153 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 14 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participant is judged to be in good health as determined from participant's medical history
  • Participant is a singleton from a full-term birth with a gestational age of 37 - 42 weeks
  • Participant's birth weight was ≥ 2490 g (\~5 lbs. 8 oz.)
  • If parent(s) elect to formula feed the participant they confirm their intention to feed their participant the study product as the sole source of feeding until 4 months of age, and as the sole milk beverage during the first 12 months of life
  • If parent(s) elect to formula feed the participant, they confirm their intention to feed the participant the assigned toddler drink from 12 months of life to 24 months of life as the primary milk beverage
  • If parent(s) elect to feed the participant mother's human milk, they confirm that their infant was exclusively fed mother's human milk since birth and confirm their intention to continue exclusively feeding human milk as the sole source of feeding through 4 months of age
  • If parent(s) of human milk fed participant elect to supplement or wean after 4 months to 24 months of age, they confirm their intention to use the supplemental/weaning formula or toddler drink as the primary milk beverage
  • Parent(s) of formula-fed participant confirm their intention not to administer vitamin or mineral supplements, from enrollment through the duration of the study
  • Parent(s) confirm their intention not to administer solid foods or juices to the participant from enrollment through 6 months of age
  • Participant's parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study.

Exclusion criteria

Exclusion Criteria:

  • An adverse maternal, fetal or participant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development
  • Participant is taking and plans to continue medications (including over the counter (OTC), home remedies, herbal preparations, prebiotics or probiotics, or rehydration fluids that might affect GI tolerance
  • Participant is in another study that has not been approved as a concomitant study
  • Participant has been treated with antibiotics prior to enrollment
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
168 participants (actual)

Study arms

  • Active comparator
    Control Feeding Group

    Ready to feed milk-based product

    Other: Control Infant Formula · Other: Control Toddler Drink

  • Experimental
    Experimental Feeding Group

    Ready to feed milk-based product with oligosaccharides

    Other: Experimental Infant Formula · Other: Experimental Toddler Drink

  • Other
    Human Milk (HM) Reference Group

    HM from infant's own mother and as needed supplemental infant formula and toddler milk-based product

    Other: Supplemental Formula for HM Group · Other: Toddler Drink for HM group

Interventions

  • OtherControl Infant Formula

    Ad libitum or as instructed by HCP, feeding period from enrollment to 12 months of age

  • OtherControl Toddler Drink

    16 fl oz per day as primary milk beverage; feeding period from 12 to 24 months of age

  • OtherExperimental Infant Formula

    Ad libitum or as instructed by HCP, feeding period from enrollment to 12 months of age

  • OtherExperimental Toddler Drink

    16 fl oz per day as primary milk beverage; feeding period from 12 to 24 months of age

  • OtherSupplemental Formula for HM Group

    Ad libitum formula given up to 12 months of age if HM is supplemented

  • OtherToddler Drink for HM group

    16 fl oz per day if weaned from HM feedings

06

What researchers measure

Primary outcomes

  1. Incidence of respiratory infection between study groups

    Adverse event reports

    Time frame: Study Day 1 to 6 Months of Age

Secondary outcomes

  1. Infection morbidity between study groups

    Adverse event reports

    Time frame: Study Day 1 to 24 Months of Age

Other outcomes

  1. Weight

    Weight in grams

    Time frame: Study Day 1 to 24 Months of Age

  2. Length

    Length in cm

    Time frame: Study Day 1 to 24 Months of Age

  3. Head Circumference (HC)

    HC in cm

    Time frame: Study Day 1 to 24 Months of Age

  4. Gastrointestinal Tolerance

    Parent completed diary

    Time frame: Study Day 1 to 119 Days of Age

  5. Dietary Intake

    Parent completed diary

    Time frame: Study Day 1 to 24 Months of Age

  6. Infant Feeding and Stool Patterns Questionnaire

    Parent completed questionnaire; 16, 5-point Likert scale questions, scaled in the negative direction

    Time frame: 28 Days of Age to 119 Days of Age

  7. Infant Behavior Questionnaire

    Parent completed questionnaire; 22 questions with 5-point Likert scale questions, scaled in the negative direction

    Time frame: 119 Days of Age

  8. Formula Satisfaction Questionnaire

    Parent completed questionnaire; 12 questions with 5-point Likert scale questions scaled in the negative direction

    Time frame: 28 Days of Age to 6 Months of Age

  9. Toddler Drink Satisfaction Questionnaire

    Parent completed questionnaire; 12 questions with 5-point Likert scale questions scaled in the negative direction

    Time frame: 15 Months of Age to 24 Months of Age

  10. Human Milk Sample

    Oligosaccharide characterization

    Time frame: 84 Days of Age

  11. Stool Sample

    Microbiota characterization

    Time frame: Study Day 1 to 24 Months of Age

  12. Saliva Sample

    Maternal-Infant secretor status

    Time frame: 84 Days of Age

  13. Modified Home Short Form

    Parent completed questionnaire; 8 questions related to the home environment adapted from the HSF compared between groups

    Time frame: 6 Months of Age to 24 Months of Age

  14. Behavioral Questionnaire

    Parent completed questionnaire; 8 questions related to sleep, physical activity and screen time

    Time frame: 12 Months of Age to 24 Months of Age

  15. Ages & Stages Questionnaire

    Parent completed questionnaire; 5 Developmental areas; Scores to the six questions in each area are totaled; Higher scores indicate more positive outcomes

    Time frame: 6 Months of Age to 18 Months of Age

  16. Bayley Scale of Infant & Toddler Development

    Examiner rated assessment; Scores are totaled and compared to normative age group data and between groups

    Time frame: 12 Months of Age to 24 Months of Age

  17. MacArthur Communicative Developmental Inventory

    Parent completed questionnaire of Words and Gestures and Words and Sentences; Percentiles compared to normative group data and between groups

    Time frame: 12 Months of Age to 24 Months of Age

  18. Edinburgh Postnatal Depression Scale

    Mother completed questionnaire; Scores for each of the 10 items are totaled; Higher scores indicate more depressive symptoms

    Time frame: 28 Days of Age

  19. Medications

    Medication usage including frequency and reason for use

    Time frame: Study Day 1 to 24 Months of Age

  20. Adverse Events

    Standard Adverse Event reporting

    Time frame: Study Day 1 to 24 Months of Age

  21. Health Resource Utilization

    Number of visits

    Time frame: Study Day 1 to 24 Months of Age

07

Study locations

27 sites
  • Southeastern Pediatric Associates
    Dothan, Alabama 36305, United States
  • Eclipse Clinical Research
    Tucson, Arizona 85745, United States
  • The Children's Clinic of Jonesboro, P.A.
    Jonesboro, Arkansas 72401, United States
  • Applied Research Center of Arkansas
    Little Rock, Arkansas 72019, United States
  • Boeson Research 3266
    Grand Junction, Colorado 81505, United States
  • TOPAZ Clinical Research, Inc.
    Apopka, Florida 32703, United States
  • ASCLEPES Research Centers
    Spring Hill, Florida 34609, United States
  • Meridian Clinical Research 3259
    Macon, Georgia 31210, United States
  • Clinical Research Prime
    Idaho Falls, Idaho 83404, United States
  • Leavitt Clinical Research
    Idaho Falls, Idaho 83404, United States
  • Qualmedica Research 3272
    Evansville, Indiana 47715, United States
  • Deaconess Clinic, Inc.
    Evansville, Indiana 47725, United States
  • Qualmedica Research, LLC 3270
    Owensboro, Kentucky 42301, United States
  • Meridian Clinical Research 3080
    Baton Rouge, Louisiana 70806, United States
  • Boeson Research 3265
    Kalispell, Montana 59901, United States
  • Boeson Research 3267
    Missoula, Montana 59804, United States
  • Meridian Clinical Research 3264
    Grand Island, Nebraska 68803, United States
  • Meridian Clinical Research 3263
    Hastings, Nebraska 68901, United States
  • Ohio Pediatric Research Association
    Dayton, Ohio 45414, United States
  • Cyn3rgy Research
    Gresham, Oregon 97030, United States
  • Holston Medical Group
    Kingsport, Tennessee 37660, United States
  • MultiCare Institute for Research & Innovation
    Dickinson, Texas 77539, United States
  • Maximos Ob/Gyn
    League City, Texas 77573, United States
  • DCOL Center for Clinical Research
    Longview, Texas 75605, United States
  • PAS Research 3273
    McAllen, Texas 78501, United States
  • Multicare Rockwood Pediatrics
    Spokane, Washington 99202, United States
  • Mercury Clinical Research 3261
    Tacoma, Washington 98405, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04495738
Lead sponsor
Abbott Nutrition
Responsible party
Sponsor
First posted
Aug 3, 2020
Start date
Aug 10, 2020
Primary completion
Apr 12, 2021
Completion
Apr 12, 2021
Last update
May 14, 2021

Study contacts

Bridget Barrett Reis, PhD, RD
study chair · Abbott Nutrition

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion